• 1. Design and synthesis of water soluble (metallo)porphyrins with pendant arms: studies of binding to xanthine oxidase
  Elizabeth A. Gibson,Anne-K. Duhme-Klair,Robin N. Perutz New J. Chem. 2010 34 1125
• 2. Molecularly imprinted polymer-based chemiluminescence imaging assay for the determination of ethopabate residues in chicken muscle
  Zhaozhou Li,Zhili Li,Daomin Li,Hongli Gao,Xiujin Chen,Li Cao,Yuze Hou,Songbiao Li Anal. Methods 2015 7 9295
• 3. Synthesis of 2-methoxybenzamide derivatives and evaluation of their hedgehog signaling pathway inhibition
  Chiyu Sun,Dajun Zhang,Tian Luan,Youbing Wang,Wenhu Zhang,Lin Lin,Meihua Jiang,Ziqian Hao,Ying Wang RSC Adv. 2021 11 22820
• 4. Development of an indirect competitive enzyme-linked immunosorbent assay for screening ethopabate residue in chicken muscle and liver
  Zhaozhou Li,Yao Wang,Daomin Li,Xiujin Chen,Zhili Li,Hongli Gao,Li Cao,Songbiao Li,Yuze Hou RSC Adv. 2017 7 36072
• 5. An efficient Au-catalyzed synthesis of isomukonidine, clausine L, mukonidine, glycosinine, mukonal, and clausine V from propadienyl methyl ether
  Youai Qiu,Dengke Ma,Chunling Fu,Shengming Ma Org. Biomol. Chem. 2013 11 1666

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in the Application of Methyl 4-amino-2-methoxybenzoate (CAS: 27492-84-8) in Chemical Biology and Pharmaceutical Research

Methyl 4-amino-2-methoxybenzoate (CAS: 27492-84-8) is a key chemical intermediate with significant applications in pharmaceutical synthesis and chemical biology research. Recent studies have highlighted its role as a versatile building block for the development of novel bioactive compounds, particularly in the areas of antimicrobial agents, anti-inflammatory drugs, and anticancer therapeutics. This research briefing provides an overview of the latest advancements involving this compound, focusing on its synthetic utility, biological activities, and potential therapeutic applications.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the use of Methyl 4-amino-2-methoxybenzoate as a precursor for the synthesis of novel quinazoline derivatives with potent antimicrobial activity against drug-resistant bacterial strains. The study reported that modifications at the 4-amino position of the benzoate scaffold significantly enhanced the compounds' ability to penetrate bacterial cell walls, leading to improved efficacy against Gram-positive pathogens. These findings suggest promising avenues for addressing the growing challenge of antibiotic resistance.

Another significant development comes from oncology research, where Methyl 4-amino-2-methoxybenzoate has been employed as a starting material for the development of small molecule inhibitors targeting protein kinases involved in cancer cell proliferation. A recent Nature Communications article (2024) detailed the structure-activity relationship studies of derivatives based on this scaffold, revealing selective inhibition of certain tyrosine kinases with minimal off-target effects. The lead compound from this series showed promising results in preclinical models of breast cancer, with improved pharmacokinetic properties compared to existing therapies.

The compound's unique chemical properties have also attracted attention in drug delivery research. A 2024 study in Advanced Drug Delivery Reviews highlighted its potential as a linker molecule in antibody-drug conjugates (ADCs), where its stability under physiological conditions and controlled release characteristics make it particularly valuable for targeted cancer therapies. The researchers emphasized that the methoxy and amino functional groups provide ideal sites for conjugation while maintaining the structural integrity of the therapeutic payload.

From a synthetic chemistry perspective, recent advances in green chemistry have explored more sustainable routes for producing Methyl 4-amino-2-methoxybenzoate. A 2023 publication in Green Chemistry reported an efficient biocatalytic method for its synthesis, reducing the environmental impact compared to traditional chemical processes. This development is particularly relevant as the pharmaceutical industry seeks to adopt more sustainable manufacturing practices without compromising product quality or yield.

Looking forward, the versatility of Methyl 4-amino-2-methoxybenzoate continues to inspire innovative applications across multiple therapeutic areas. Current research directions include its incorporation into PROTAC (proteolysis targeting chimera) molecules for targeted protein degradation and its use as a fluorescent probe in cellular imaging studies. The compound's well-characterized properties and commercial availability make it an attractive starting point for both academic and industrial research programs in chemical biology and drug discovery.

• 2486-80-8(4-Amino-2-methoxybenzoic acid)
• 4136-97-4(Methyl 4-aminosalicylate)
• 133-11-9(Phenyl 4-Aminosalicylate)
• 22802-67-1(Methyl 5-Amino-2-methoxybenzoate)
• 42753-75-3(5-Amino-2-hydroxybenzoic Acid Methyl Ester)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)